A blog about chemistry, drug development, science, and technology
Things just seem to keep getting worse for the FDA and the pharma industry. Now it seems former FDA commissioner Lester Crawford is under criminal investigation for financial improprieties and making false statements to Congress. It seemed that something was wrong when just after having been confirmed by congress he abruptly resigned.
The story is on MSNBC but the original article is from the New York Times (registration required). Seems Lester Crawford sold $50,000 in stocks in a company regulated by the FDA shortly after his confirmation and shortly before his resignation. I couldn’t find any other details in a brief search but since the information was obtained through a Freedom of Information Act (FOIA) filing it should be known. A Yahoo and Google news search didn’t turn up the name of the company involved but it came out during a court hearing related to the Plan B fiasco. If the stock he sold ends up being Barr Labs that would be an obvious conflict of interest.
Here is the Google listing of all 131 related news articles (as of Saturday night, Apr 29), but they all say pretty much the same thing.
I’m sure we’ll be hearing more about this in the days or weeks to come.
Technorati Tags: FDA
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.230 seconds